Schizophrenia News

Study findings in Neuron indicate mutations linked to schizophrenia disrupt specific sets of genes that control excitatory and inhibitory signals, which play an essential role in healthy brain development and function.

In an effort to further scientific knowledge of schizophrenia, Johnson and Johnson recently announced Janssen Research and Development, LLC, is partnering with a number of research organizations to launch the Open Translational Science in Schizophrenia project.

Creativity may be a predictor of schizophrenia and bipolar disorder, as recent study findings indicate that creative individuals were more likely to have one of the disorders.

A cognitive enhancement program improved employment outcomes for participants with severe mental illness, according to data recently published in The American Journal of Psychiatry.

Analysis of a large national cohort showed mood instability was common across many mental disorders and led to higher rates of hospitalization and antipsychotic treatment.

TORONTO —According to phase 3 study results presented here, Latuda, an atypical antipsychotic agent, significantly reduced depressive symptoms among adults with major depressive disorder with limited manic symptoms.

Approximately two-thirds of the general population that report psychotic episodes only experience one to five episodes during their lifetime, according to data from a cross-national analysis.

Data from the MacArthur Violence Risk Assessment Study suggest that psychosis precedes violent acts some of the time among individuals with repeated involvement with violence, but is uncommon and inconsistent.

Janssen Pharmaceuticals announced today the FDA has approved Invega Trinza, a three-month long-acting atypical antipsychotic, under priority review for the New Drug Application for treatment of schizophrenia.

TORONTO — Identifying differences in diagnostic practices among psychiatrists across the world can help improve cultural competency among clinicians, according to data presented here at the American Psychiatric Association Annual Meeting.